Readers might consider the challenge of securing the minister's time in the Albanese Government's first term. With the addition of the NDIS, and even with a supporting minister, as the Cabinet representative, Mr Butler's time is going to become even more precious.
Portfolio change has real implications for stakeholders, with a revised approach required
May 15, 2025 Latest NewsBioPharmaComment
Latest Video
New Stories
-
USTR launches new investigation, with minimal ambition on pharmaceuticals
July 17, 2025 - - Latest News -
Mark Butler restates support for health technology assessment reform
July 16, 2025 - - Latest News -
Brandon BioCatalyst welcomes the inclusion of its CUREator in new program
July 16, 2025 - - Australian Biotech -
Cancer Australia launches research program targeting early-onset cancers
July 16, 2025 - - Latest News -
Imugene completes significant placement and launches share purchase plan
July 16, 2025 - - Australian Biotech -
Lumos Diagnostics signs FebriDx US Distribution Agreement with PHASE Scientific
July 16, 2025 - - Australian Biotech -
Noxopharm confirms first patient dosed in SOF-SKN HERACLES trial
July 16, 2025 - - Australian Biotech